Announcements Trials
Browse Landscape

Status

Completed 27Recruiting 11Unknown 8Active not recruiting 6Terminated 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 69Breast Neoplasms 68Prostatic Neoplasms 48Lung Neoplasms 34Carcinoma, Non-Small-Cell Lung 26Colorectal Neoplasms 19Pancreatic Neoplasms 17Carcinoma, Hepatocellular 16Brain Neoplasms 15Leukemia, Myeloid, Acute 14Lymphoma 13Colonic Neoplasms 13Carcinoma, Renal Cell 13Melanoma 12Head and Neck Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Ovarian Neoplasms 11Neoplasm Metastasis 10Lymphoma, Non-Hodgkin 10Leukemia, Lymphocytic, Chronic, B-Cell 10Hematologic Neoplasms 10Uterine Cervical Neoplasms 9Liver Neoplasms 9Multiple Myeloma 8Leukemia 8Glioblastoma 8Stomach Neoplasms 7Recurrence 7Papillomavirus Infections 7Hodgkin Disease 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Observational × Cognitive Dysfunction × Clear all
NCT01045044 2012-04-05

Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy

Kettering Health Network

Withdrawn
Breast

Breast Neoplasms, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡